Browsing: gpp

Spesolimab approved in Malaysia for the treatment of Generalized Pustular Psoriasis flares in adults

By Boehringer IngelheimDecember 13, 20240

The National Pharmaceutical Regulatory Agency (NPRA) Malaysia has approved Spesolimab (marketed as SPEVIGO®) for the treatment of flares in adults with generalized pustular psoriasis (GPP), the first indicated treatment of its kind in Malaysia.

Boehringer Ingelheim Unveils Art Collection Showcasing Rare Skin Disease at World Congress of Dermatology

By MCA TeamJuly 14, 20230

Boehringer Ingelheim showcases The Unwearable Collection™ in collaboration with Bart Hess to raise awareness about generalized pustular psoriasis (GPP).

About
Advertise
Contact Us
Privacy Policy

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Cats Infected with Bird Flu in the US Raise Alarm Over Mutations

Sleep Tips for Teens to Get Back-to-School Ready

A Beginner’s Guide to Kickstart Your Fitness Journey in the New Year

Browsing: gpp

Spesolimab approved in Malaysia for the treatment of Generalized Pustular Psoriasis flares in adults

Boehringer Ingelheim Unveils Art Collection Showcasing Rare Skin Disease at World Congress of Dermatology

Cats Infected with Bird Flu in the US Raise Alarm Over Mutations

Sleep Tips for Teens to Get Back-to-School Ready

A Beginner’s Guide to Kickstart Your Fitness Journey in the New Year

Zyrtec-D Discontinued in Singapore Amid Safety Concerns

Subscribe to Updates

What's Hot

Browsing: gpp

Subscribe to Updates